Form 483

University Rx Specialists Inc Form 483, 2015-09-21

FDA issued a Form 483 to University Rx Specialists Inc on 2015-09-21 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

University Rx Specialists Inc · San Diego, United States · Issued September 21, 2015

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Sep 2015
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Linda Thai

21 Sep 2015
21 CFR 211.165(a)

Testing and release for distribution

Cited by Linda Thai

21 Sep 2015
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Linda Thai

21 Sep 2015
21 CFR 211.28(a)

Protective Apparel Not Worn

Cited by Linda Thai

21 Sep 2015
21 CFR 211.42(c)(10)(iii)

Air Supply

Cited by Linda Thai

Inspected site

URUniversity Rx Specialists IncSan Diego, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere